Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on April 8, 2008
JNCI Journal of the National Cancer Institute 2008 100(8):526-528; doi:10.1093/jnci/djn121
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/8/526    most recent
djn121v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Beres, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beres, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

NEWS

Filling the Gaps To Fight Cervical Cancer

Samantha Beres

The first 150 words of the full text of this article appear below.

Pap screening programs have substantially reduced the incidence of cervical cancer, yet it is hard to deny the promise of human papillomavirus (HPV) vaccines for further reducing the burden of this preventable disease. The two available vaccines—Merck's Gardasil and GlaxoSmithKline's Cervarix—target the most common HPV types that are responsible for 70% of cervical cancers. In girls not previously exposed to HPV, both vaccines have shown nearly 100% efficacy against these HPV strains.

But not all women at risk for cervical cancer are benefiting from these preventive measures. Millions of women and girls do not receive Pap screening, nor are they able to get the vaccine, particularly in resource-poor countries where education, access, and money are lacking. Also, the vaccines don’t protect against all HPV strains that cause the disease, and they do not treat existing HPV infections. At greatest risk are those who have been exposed to the virus and . . . [Full Text of this Article]

Cheaper Vaccine Delivery

New Screening Tools

Cervical Cancer lnterventions: Not One Size Fits All


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?